Clinical trials
Phase 4 Crohn Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 9 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 7 |
| Alimentiv Inc. | 3 |
| Mayo Clinic | 3 |
| Cedars-Sinai Medical Center | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| AbbVie | 1 |
| Atlanta Gastroenterology Associates | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Biogen | 1 |
| Connecticut Children's Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 40 |
| Colitis, Ulcerative | 13 |
| Inflammatory Bowel Diseases | 11 |
| Arthritis, Psoriatic | 2 |
| Psoriasis | 2 |
| Arthritis, Rheumatoid | 1 |
| Clostridium Infections | 1 |
| Colorectal Neoplasms | 1 |
| Digestive System Diseases | 1 |
| Gastrointestinal Diseases | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.